Telehealth is no longer a novelty in behavioral health. It’s an operating reality.

What has changed recently is how buyers underwrite it. In today’s market, telehealth can be a meaningful value driver inside a well-run practice. But as a stand-alone story, it rarely commands a premium unless the economics, compliance posture, and payer access are unusually strong.

What Does Buyer Appetite Look Like For Telehealth Behavioral Health Businesses?

Buyers are still transacting in virtual behavioral health, but the pattern matters. The most visible deals tend to be strategic tuck-ins that add a capability (network access, a pediatric workflow, an outcomes engine, or payer relationships), rather than “growth-at-all-costs” bets on pure direct-to-consumer teletherapy.

A few examples:

• Teladoc acquired UpLift (a virtual mental health provider) in April 2025 for $30M cash plus up to $15M earnout, positioning it as a way to expand insurance-covered mental health access.
• Kooth acquired Kismet Health’s pediatric telehealth platform (Nov 2025) to expand its digital mental health reach and capabilities.
• Uwill acquired Virtual Care Group (July 2024) to scale tele-mental health access in higher education.
• Cerebral acquired Resilience Lab (announced Aug 2025), a deal framed around expanding an outcomes-focused care model and clinician development platform.

So yes, pure-play and mostly virtual platforms do get acquired. But the “why” is telling: payers, networks, clinical infrastructure, and defensible delivery models are what attract buyers, not telehealth as a modality.

This is also why many pure-play, consumer-heavy models are viewed cautiously. Teladoc’s BetterHelp has been a public case study in the headwinds: rising customer acquisition costs, performance pressure, and a large impairment tied to the segment. (Reuters) If your telehealth revenue is fueled by paid acquisition and high churn, buyers tend to underwrite it as fragile.

The Underwriting Reality: Telehealth Isn’t “Extra,” It’s Risk-Adjusted

In valuation terms, telehealth revenue is typically treated in one of two ways:

1) Durable access channel (positive):
Telehealth expands capacity, reduces no-shows, improves clinician utilization, and keeps patients “in the system” for follow-ups and medication management. In this case, it can support a stronger multiple because it’s embedded into a repeatable care engine.

2) Volatile revenue stream (discounted):
Telehealth becomes a diligence problem if it’s highly dependent on one clinician, one state, one payer policy, or one marketing channel. Buyers will price that uncertainty through structure (earnouts/holdbacks) or a lower multiple.

A major diligence lens here is policy and reimbursement stability. For example, Medicare’s behavioral/mental health telehealth rules have been moving through extensions and deadlines, including temporary delays of in-person requirements (currently extended in federal guidance through January 30, 2026). (telehealth.hhs.gov) Even if Medicare is not your main payer, policy volatility signals “rule risk” and buyers notice.

If Telehealth Is Part Of Your Behavioral Health Practice, How To Leverage It As A Value Driver

If telehealth is a portion of your delivery model, your goal is to show it makes the practice stronger, not just more convenient.

Here’s what that looks like in a sale process:

Show telehealth is integrated into operations, not improvised

Buyers respond to telehealth when it’s clearly part of a standardized workflow:

• Intake → scheduling → clinical documentation → follow-up cadence
• Clear clinical governance (supervision, QA, documentation standards)
• Measurable throughput and continuity (time-to-first-visit, visit frequency, retention)

Prove it improves access and utilization (not cancellations and churn)

Telehealth is compelling when you can demonstrate:

• Increased capacity without sacrificing clinical quality
• Reduced lead leakage (faster appointment availability)
• Better continuity for step-down care, follow-ups, med management, or group sessions

De-risk payers and show real reimbursement behavior

Telehealth becomes a valuation lever when collections are predictable and payer processes are established. In diligence, buyers want clean answers on:

• Allowed amounts vs. in-person
• Denial patterns and appeal process
• Any payer concentration tied specifically to telehealth

Position telehealth as a growth tool buyers can scale

The best positioning is not “we do telehealth.” It’s “telehealth is how we serve more patients and retain them.”

If you can show a repeatable playbook, especially for hybrid care models, telehealth reads as a scalable channel that supports growth under a new owner.

Conclusion

Telehealth can absolutely increase buyer interest in behavioral health, but only when it’s built like an operating advantage.

Pure-play virtual models can transact, and recent deals show buyers will buy telehealth capabilities when they add something defensible: payer access, outcomes infrastructure, clinician development, or specialized platform functionality. What buyers are not paying up for right now is “telehealth as a story” without proof that the revenue is stable, compliant, and repeatable.

If you’re planning a sale, the winning approach is simple: make telehealth a system, not a feature then document the performance like a buyer is already in the room.